PATENT CLAIM ANALYSIS

Application Number: 16264155
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "267000"]

Abstract:
The present invention refers to the use of sodium channel blockers such as tetrodotoxin or saxitoxin, its analogues/derivatives as well as their acceptable salts, for the production of a medicament for the treatment of neuropathic pain resulting from chemotherapy.

Claim (Index 32):
The method of  claim 29 , wherein the one or more of tetrodotoxin, an analog, derivative, or pharmaceutically acceptable salt thereof is administered in combination with at least one chemotherapeutic agent.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 99.0
- Lexical Diversity: 1.23529
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12294843', '15268378', '13420111', '13258529', '11295730']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7796234456691087
- 35 USC 102 Novelty (BERT): 0.5598852272818479
- Combined Prediction Score: 0.7576496238303826
- Mean Citation Score: 304.825142
- Max Citation Score: 461.40143
- Similarity Product: 316.3315046215284

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test